At the end of the latest market close, GT Biopharma Inc. (GTBP) was valued at $7.19. In that particular session, Stock kicked-off at the price of $7.20 while reaching the peak value of $8.49 and lowest value recorded on the day was $6.65. The stock current value is $8.24.
Recently in News on March 29, 2021, GT Biopharma’s TriKE™ Interim Clinical Trial Results Presented At Innate Killer Summit 2021. Outlines the Clinical Power of Immune Engagement with IL-15 Containing TriKEs. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
GT Biopharma Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.35 on 01/12/21, with the lowest value was $3.90 for the same time period, recorded on 03/05/21.
GT Biopharma Inc. (GTBP) full year performance was 223.14%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, GT Biopharma Inc. shares are logging -37.05% during the 52-week period from high price, and 303.59% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.04 and $13.09.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1287201 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the GT Biopharma Inc. (GTBP) recorded performance in the market was 14.32%, having the revenues showcasing 14.32% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 200.56M, as it employees total of 2 workers.
The Analysts eye on GT Biopharma Inc. (GTBP)
During the last month, 0 analysts gave the GT Biopharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.00, with a change in the price was noted +5.18. In a similar fashion, GT Biopharma Inc. posted a movement of +168.98% for the period of last 100 days, recording 255,502 in trading volumes.
Technical rundown of GT Biopharma Inc. (GTBP)
Raw Stochastic average of GT Biopharma Inc. in the period of last 50 days is set at 94.35%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 93.87%. In the last 20 days, the company’s Stochastic %K was 97.96% and its Stochastic %D was recorded 97.38%.
Considering, the past performance of GT Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 14.32%. Additionally, trading for the stock in the period of the last six months notably improved by 165.59%, alongside a boost of 223.14% for the period of the last 12 months. The shares increased approximately by 21.89% in the 7-day charts and went down by 87.27% in the period of the last 30 days. Common stock shares were driven by 14.32% during last recorded quarter.